Coccidest
Toltrazuril
Composition
Each 1 ml contains:
Toltrazuril 25 mg
Properties
Toltrazuril disrupts the fine structure of coccidial development stages, causing swelling of the endoplasmic reticulum and Golgi apparatus, nuclear abnormalities, and reduced respiratory-chain enzyme activity, with no anticoagulant, analgesic or cardiac effects observed in laboratory studies.
Indications
Treatment and control of coccidiosis, active against all intestinal stages of susceptible coccidia; supports development of natural immunity in breeder and layer replacement stock under continuous challenge.
Dosage & Administration
Orally in drinking water.
Active ingredient: 7 mg/kg body weight.
Whole product: 280 ml / 100 kg body weight in drinking water for 25 successive days (2.5–3 ml/litre).
Warnings & Precautions
Compatible with antibiotics such as enrofloxacin, ampicillin, tetracycline, tiamulin and tylosin. Not for use in chickens producing eggs for human consumption.
Side Effects
None at the recommended dose.
Withdrawal Time
21 days
Storage
Store below 30°C.
Package
HDPE bottle, 25 ml – 1000 ml and 1–25 litre.
